Improving dementia care for patients and caregivers during COVID-19
The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19
This study is testing a new way to support people with dementia and their caregivers by using a team of trained helpers who provide care and guidance over the phone and online, aiming to make life easier and less stressful for everyone involved.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10852962 on NIH RePORTER |
What this research studies
This research focuses on enhancing dementia care through a new model called the Care Ecosystem, which provides accessible, remote support for patients and their caregivers. The approach involves a team of trained Care Team Navigators who deliver care via phone and web, guided by protocols developed by dementia specialists. The goal is to improve patient outcomes, reduce emergency visits, and alleviate caregiver stress, particularly in the context of challenges posed by the COVID-19 pandemic. The research will be conducted across six diverse health systems to ensure broad applicability and effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with dementia and their caregivers, particularly those affected by the COVID-19 pandemic.
Not a fit: Patients with early-stage dementia or those not requiring caregiver support may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved quality of life for dementia patients and reduced burden on their caregivers.
How similar studies have performed: Previous research has shown that similar team-based care models can improve outcomes for dementia patients and their caregivers, indicating a promising approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Possin, Katherine Laurel — University of California, San Francisco
- Study coordinator: Possin, Katherine Laurel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.